文献速递妇科

澳大利亚可预防的子宫内膜癌和卵巢癌负担:一项汇总队列研究

The preventable burden of endometrial and ovarian cancers in Australia: A pooled cohort study.
PubMed 文献 · Gynecol Oncol · 2019-03-29

本研究链接六项澳大利亚队列研究与国家癌症和死亡登记数据,量化行为与激素暴露相关的可预防子宫内膜癌和卵巢癌负担。中位随访4.9年期间诊断510例子宫内膜癌和303例卵巢癌,超重和肥胖可解释41.9%的子宫内膜癌负担,仅肥胖即解释34.5%,而卵巢癌归因于超重、肥胖或外源性激素的负担未达统计学显著。

要点

  • 超重和肥胖可解释41.9%的子宫内膜癌负担,仅肥胖解释34.5%。
  • 从不使用口服避孕药可解释8.1%的子宫内膜癌负担。
  • 卵巢癌归因于超重、肥胖或外源性激素的负担未达统计学显著。

核心结论

  • 超重和肥胖这一全球高流行且不断上升的特征,导致了大部分子宫内膜癌负担,提示需要采取有效策略减少肥胖。

研究设计与样本

  • 汇总六项澳大利亚队列研究,链接国家癌症和死亡登记,使用校正比例风险模型量化暴露与癌症关联,并从代表性健康调查估计暴露 prevalence,计算考虑死亡竞争风险的人群归因分数(PAFs)及95%置信区间(CIs)。
  • 中位随访4.9年,诊断510例子宫内膜癌和303例卵巢癌。

主要发现

  • 超重和肥胖可解释子宫内膜癌负担的41.9%(95% CI 32.3-50.1),仅肥胖解释34.5%(95% CI 27.5-40.9),分别相当于未来10年澳大利亚12,800例和10,500例子宫内膜癌。
  • 在患有糖尿病、居住偏远、年龄较大、社会经济地位或教育程度较低以及出生于澳大利亚的女性中,体脂相关的子宫内膜癌负担最高(49-87%)。
  • 从不使用口服避孕药可解释8.1%(95% CI 1.8-14.1)的子宫内膜癌负担,即2,500例子宫内膜癌。
  • 较高的BMI和当前长期使用绝经激素治疗增加卵巢癌风险,而长期使用口服避孕药降低卵巢癌风险,但归因于超重、肥胖或外源性激素因素的负担未达统计学显著。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Evidence on the endometrial and ovarian cancer burden preventable through modifications to current causal behavioural and hormonal exposures is limited. Whether the burden differs by population subgroup is unknown. METHODS: We linked pooled data from six Australian cohort studies to national cancer and death registries, and quantified exposure-cancer associations using adjusted proportional hazards models. We estimated exposure prevalence from representative health surveys. We then calculated Population Attributable Fractions (PAFs) with 95% confidence intervals (CIs), accounting for competing risk of death, and compared PAFs for population subgroups. RESULTS: During a median 4.9 years follow-up, 510 incident endometrial and 303 ovarian cancers were diagnosed. Overweight and obesity explained 41.9% (95% CI 32.3-50.1) of the endometrial cancer burden and obesity alone 34.5% (95% CI 27.5-40.9). This translates to 12,800 and 10,500 endometrial cancers in Australia in the next 10 years, respectively. The body fatness-related endometrial cancer burden was highest (49-87%) among women with diabetes, living remotely, of older age, lower socio-economic status or educational attainment and born in Australia. Never use of oral contraceptives (OCs) explained 8.1% (95% CI 1.8-14.1) or 2500 endometrial cancers. A higher BMI and current long-term MHT use increased, and long-term OC use decreased, the risk of ovarian cancer, but the burden attributable to overweight, obesity or exogenous hormonal factors was not statistically significant. CONCLUSIONS: Excess body fatness, a trait that is of high and increasing prevalence globally, is responsible for a large proportion of the endometrial cancer burden, indicating the need for effective strategies to reduce adiposity.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Laaksonen MA, Arriaga ME, Canfell K, et al. The preventable burden of endometrial and ovarian cancers in Australia: A pooled cohort study. Gynecol Oncol. 2019. PMID: 30935715. doi:10.1016/j.ygyno.2019.03.102

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。